Serum IL-17A in Behcet's disease


Creative Commons License

Emiroglu N., Cengiz F. P. , ERDEM G. B.

POSTEPY DERMATOLOGII I ALERGOLOGII, vol.32, no.5, pp.358-361, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.5114/pdia.2015.54745
  • Journal Name: POSTEPY DERMATOLOGII I ALERGOLOGII
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.358-361

Abstract

Introduction: Behcet's disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet's disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.